Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 15, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 15, 2024Not yet recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:March 12, 2024Not yet recruiting
Condition(s):Metabolic Diseases; Aerobic ExerciseLast Updated:March 8, 2024Recruiting
Condition(s):Well-Being, PsychologicalLast Updated:March 8, 2024Not yet recruiting
Condition(s):AsthmaLast Updated:March 12, 2024Recruiting
Condition(s):Early-stage Breast CancerLast Updated:March 6, 2024Not yet recruiting
Condition(s):Depression; Anxiety; Depression/AnxietyLast Updated:March 5, 2024Not yet recruiting
Condition(s):Healthy VolunteersLast Updated:March 1, 2024Recruiting
Condition(s):Healthy VolunteerLast Updated:March 1, 2024Recruiting
Condition(s):HIVLast Updated:February 23, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.